Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH138889FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. Fosun Pharma provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company’s research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd Key Recent Developments

Mar 29,2021: Fosun Pharma Announces 2020 Annual Results
Nov 12,2020: Shanghai Fosun Pharmaceutical : Overseas regulatory announcement
Oct 30,2020: Fosun Pharma announces 2020 third quarterly report innovative drug development entered intensive harvest period and performance continued steady growth
Oct 29,2020: Shanghai Fosun Pharmaceutical : Change of chairman and authorised representative re-designation of directors and adjustment of senior management
Aug 26,2020: Fosun Pharma announces 2020 interim results

This comprehensive SWOT profile of Shanghai Fosun Pharmaceutical (Group) Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shanghai Fosun Pharmaceutical (Group) Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Information
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Overview
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employees
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Employee Biographies
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Operational Heads
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Major Products and Services
Shanghai Fosun Pharmaceutical (Group) Co Ltd – History
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Company Statement
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Locations And Subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Business Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Corporate Strategy
Shanghai Fosun Pharmaceutical (Group) Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Strengths
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Weaknesses
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Opportunities
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Threats
Shanghai Fosun Pharmaceutical (Group) Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shanghai Fosun Pharmaceutical (Group) Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Information
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Ratios
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Share Data
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Major Products and Services
Shanghai Fosun Pharmaceutical (Group) Co Ltd, History
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employee Biographies
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Operational Heads
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Other Locations
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors
Shanghai Fosun Pharmaceutical (Group) Co Ltd, SWOT Analysis
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Ratios based on current share price
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Annual Ratios
Shanghai Fosun Pharmaceutical (Group) Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hidd Power Company:企業の戦略的SWOT分析
    Hidd Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Nan Ya Plastics Corporation:企業の戦略・SWOT・財務情報
    Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report Summary Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Stryker Corporation (SYK)-医療機器分野:企業M&A・提携分析
    Summary Stryker Corporation (Stryker) is one of the leading manufacturers of medical equipment. It offers reconstructive, medical and surgical, and neurotechnology and spine products. Its major products include implants; surgical equipment and surgical navigation systems; endoscopic and communicatio …
  • Integrity Applications Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Integrity Applications Ltd (Integrity Applications) is a medical device company that designs, develops and markets non-invasive glucose monitoring devices. The company develops GlucoTrack, a glucose monitoring device which utilizes ultrasonic, electromagnetic and thermal technologies to meas …
  • Galen Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd, is a pharmaceutical company. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipa …
  • CHS Inc (CHSCP):石油・ガス:M&Aディール及び事業提携情報
    Summary CHS Inc. (CHS) is an integrated agribusiness company, which provides grain, foods and energy resources to businesses and consumers. It is a cooperative owned by farmers and ranchers and their member cooperatives across the US. The company provides a broad range of products and services, from …
  • Civica Group Limited:企業の戦略的SWOT分析
    Civica Group Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of ne …
  • GRP Limited (GRPLTD):企業の財務・戦略的SWOT分析
    GRP Limited (GRPLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Biolase Inc (BIOL):企業の財務・戦略的SWOT分析
    Biolase Inc (BIOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Endo Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Endo Pharmaceuticals Inc (Endo Pharmaceuticals), a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and over-the-counter medications. Its products include testostero …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Beazer Homes USA, Inc.:企業の戦略・SWOT・財務分析
    Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genworth Financial, Inc.:企業のM&A・事業提携・投資動向
    Genworth Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genworth Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Koki Holdings Co Ltd:企業の戦略的SWOT分析
    Koki Holdings Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • NAPEC Inc:電力:M&Aディール及び事業提携情報
    Summary NAPEC Inc (NAPEC), is a subsidiary of Oaktree Capital Management, L.P., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company instal …
  • PTC Therapeutics Inc (PTCT)-製薬・医療分野:企業M&A・提携分析
    Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mu …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • ObsEva SA (OBSV):企業の財務・戦略的SWOT分析
    ObsEva SA (OBSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆